Patents Assigned to Peptech, Ltd.
  • Sustained GnRH peptide-release formulation
    Patent number: 6337318
    Abstract: A pharmaceutical and/or veterinary formulation for sustained release of a peptide agonist or analogue, comprising about 2-15% (w/w) of at least one peptide agonist or analogue other than deslorelin (on an active basis), about 0.5-3.5% (w/w) lecithin and the balance stearin. The formulation preferably comprises a GnRH agonist or analogue and is used for the treatment of various conditions where suppression of sex hormone levels is beneficial, particularly prostate cancer, ovarian and breast cancer, and benign prostatic hyperplasia in dogs.
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: January 8, 2002
    Assignee: Peptech, Ltd.
    Inventors: Timothy Elliot Trigg, John Desmond Walsh, Paul Adam Schober